USPTO 2015–2025 USPTO PatentsView US Corporation

Pattern Bioscience, Inc.

USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

11
Total patents granted
5
CPC technology areas
14.2
Avg claims per patent
-
5-year filing velocity

The verdict

Pattern holds 11 US patents across 5 technology areas, rank #24,989 of 50,000 tracked assignees.

#24,989
of 50,000 US assignees by volume
Top 35%
by Innovation Score (40.5/100)
14.2
avg claims per patent

Portfolio overview

Pattern Bioscience, Inc. has been granted 11 US utility patents between 2020 and 2025, placing Pattern Bioscience, Inc. at rank #24,989 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.2 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Pattern Bioscience, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Pattern sits between Paper-pak Industries (11 patents, rank #24,985) and Perceptimed, Inc. (11 patents, rank #24,993) - the closest US assignees by grant volume. The composite Innovation Score of 40.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 11 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Pattern Bioscience, Inc.'s 14.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Pattern Bioscience, Inc. against peers pursuing similar technology classes.

Who files at Pattern's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Pattern holds 11 patents at rank #24,989, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Pattern's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard

Where it ranks

Overall rank by patents

#24,989

Across all tracked assignees

Innovation Score

40.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Pattern Bioscience, Inc. hold?
Pattern Bioscience, Inc. holds 11 US granted patents filed between 2020 and 2025, spanning 5 technology areas.
What is Pattern Bioscience, Inc.'s Innovation Score?
Pattern Bioscience, Inc. has an Innovation Score of 40.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Pattern Bioscience, Inc. focus on?
Pattern Bioscience, Inc.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 9 patents. The company has filed patents in 5 CPC subclasses total.
Is Pattern Bioscience, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Pattern Bioscience, Inc..
What does claim depth mean for Pattern Bioscience, Inc.'s patents?
Pattern Bioscience, Inc.'s patents average 14.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the Pattern Bioscience, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Pattern's 11 grants land it in the top 35% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Pattern ranks #24,989 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.